Increased visceral arterial tortuosity in Marfan syndrome.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 13 03 2019
accepted: 31 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 22 6 2021
Statut: epublish

Résumé

Clinical evidence suggests that the currently recommended approach to estimate the risk of aortic dissection in Marfan syndrome (MFS) is not reliable enough. Therefore, we investigated the possible role of visceral arterial tortuosity in the risk stratification. Splenic and renal arteries of 37 MFS patients and 74 age and gender matched control subjects were segmented using CT angiography imaging. To measure tortuosity, distance metric (DM), sum of angles metric (SOAM), inflection count metric (ICM), and the ratio of ICM and SOAM (ICM/SOAM) were calculated. DM of the splenic, right and left renal artery was significantly higher in MFS patients than in controls (2.44 [1.92-2.80] vs. 1.75 [1.57-2.18] p < 0.001; 1.16 [1.10-1.28] vs. 1.11 [1.07-1.15] p = 0.011; 1.40 [1.29-1.70] vs. 1.13 [1.09-1.23] p < 0.001, respectively). A similar tendency for ICM and an opposite tendency for SOAM were observed. ICM/SOAM was significantly higher in the MFS group compared to controls in case of all three arteries (73.35 [62.26-93.63] vs. 50.91 [43.19-65.62] p < 0.001; 26.52 [20.69-30.24] vs. 19.95 [16.47-22.95] p < 0.001; 22.81 [18.64-30.96] vs. 18.38 [15.29-21.46] p < 0.001, respectively). MFS patients who underwent aortic root replacement had increased right and left renal DM and ICM/SOAM compared to MFS patients without surgery. To our knowledge this is the first demonstration of increased arterial tortuosity in MFS on visceral arteries. Visceral arterial tortuosity, dominated by curves of lower frequency but higher amplitude according to the observed opposite tendency between the DM and SOAM metrics, could be a possible new predictor of serious manifestations of MFS.

Sections du résumé

BACKGROUND
Clinical evidence suggests that the currently recommended approach to estimate the risk of aortic dissection in Marfan syndrome (MFS) is not reliable enough. Therefore, we investigated the possible role of visceral arterial tortuosity in the risk stratification.
METHODS AND RESULTS
Splenic and renal arteries of 37 MFS patients and 74 age and gender matched control subjects were segmented using CT angiography imaging. To measure tortuosity, distance metric (DM), sum of angles metric (SOAM), inflection count metric (ICM), and the ratio of ICM and SOAM (ICM/SOAM) were calculated. DM of the splenic, right and left renal artery was significantly higher in MFS patients than in controls (2.44 [1.92-2.80] vs. 1.75 [1.57-2.18] p < 0.001; 1.16 [1.10-1.28] vs. 1.11 [1.07-1.15] p = 0.011; 1.40 [1.29-1.70] vs. 1.13 [1.09-1.23] p < 0.001, respectively). A similar tendency for ICM and an opposite tendency for SOAM were observed. ICM/SOAM was significantly higher in the MFS group compared to controls in case of all three arteries (73.35 [62.26-93.63] vs. 50.91 [43.19-65.62] p < 0.001; 26.52 [20.69-30.24] vs. 19.95 [16.47-22.95] p < 0.001; 22.81 [18.64-30.96] vs. 18.38 [15.29-21.46] p < 0.001, respectively). MFS patients who underwent aortic root replacement had increased right and left renal DM and ICM/SOAM compared to MFS patients without surgery.
CONCLUSION
To our knowledge this is the first demonstration of increased arterial tortuosity in MFS on visceral arteries. Visceral arterial tortuosity, dominated by curves of lower frequency but higher amplitude according to the observed opposite tendency between the DM and SOAM metrics, could be a possible new predictor of serious manifestations of MFS.

Identifiants

pubmed: 32293489
doi: 10.1186/s13023-020-01369-w
pii: 10.1186/s13023-020-01369-w
pmc: PMC7160945
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

91

Références

J Stroke Cerebrovasc Dis. 2000 Jul-Aug;9(4):196-8
pubmed: 24192028
Brain Dev. 2001 Jul;23(4):251-4
pubmed: 11377006
BMC Cardiovasc Disord. 2014 Apr 11;14:47
pubmed: 24720641
Int J Stroke. 2015 Oct;10(7):1081-6
pubmed: 26061533
Circulation. 2011 Jul 26;124(4):388-96
pubmed: 21730308
Curr Opin Cardiol. 2015 Nov;30(6):587-93
pubmed: 26398550
Ann Genet. 2004 Jan-Mar;47(1):1-9
pubmed: 15127738
IEEE Trans Med Imaging. 2003 Sep;22(9):1163-71
pubmed: 12956271
Circ J. 2011;75(9):2135-43
pubmed: 21712608
Genet Med. 2018 Oct;20(10):1236-1245
pubmed: 29323665
Orv Hetil. 2012 Feb 26;153(8):296-302
pubmed: 22330841
Angiology. 1998 May;49(5):361-71
pubmed: 9591528
Eur Radiol. 2015 Mar;25(3):872-82
pubmed: 25316057
Cardiol J. 2013;20(3):227-34
pubmed: 23788295
Int J Cardiol. 2015 Sep 1;194:7-12
pubmed: 26005802
Int J Cardiol. 2015 Apr 1;184:22-7
pubmed: 25705006
Neurochirurgie. 1988;34(5):342-7
pubmed: 3231295
J Thorac Dis. 2018 Apr;10(4):2456-2460
pubmed: 29850152
Thromb Haemost. 2015 Oct;114(4):748-56
pubmed: 26063524
J Pediatr Surg. 2010 Jan;45(1):193-9
pubmed: 20105603
J Med Genet. 2010 Jul;47(7):476-85
pubmed: 20591885
Heart. 2014 Oct;100(20):1571-6
pubmed: 24986892
Eur Heart J. 2012 Oct;33(19):2451-96
pubmed: 22922415
Ann Cardiothorac Surg. 2017 Nov;6(6):582-594
pubmed: 29270370
Radiographics. 2018 Jan-Feb;38(1):275-286
pubmed: 29320330
Atherosclerosis. 2010 Mar;209(1):211-4
pubmed: 19717156
J Pediatr. 1989 Dec;115(6):954-8
pubmed: 2585234
Hum Mol Genet. 2010 Oct 1;19(19):3721-33
pubmed: 20639396
J Thorac Cardiovasc Surg. 2012 Feb;143(2):282-6
pubmed: 22104675
Lancet. 2005 Dec 3;366(9501):1965-76
pubmed: 16325700
J Cardiothorac Surg. 2016 Jan 22;11:19
pubmed: 26801237
Eur Spine J. 2016 Oct;25(10):3288-3293
pubmed: 27142807
Eur J Pediatr. 2014 May;173(5):671-5
pubmed: 24276535
J Cardiovasc Med (Hagerstown). 2017 May;18(5):305-310
pubmed: 27136701
Eur J Cardiothorac Surg. 2005 Dec;28(6):857-63
pubmed: 16275113

Auteurs

Bence Ágg (B)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary. agg.bence@med.semmelweis-univ.hu.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary. agg.bence@med.semmelweis-univ.hu.
Department of Pharmacology and Pharmacotherapy, Semmelweis University, Üllői út 26, Budapest, H-1085, Hungary. agg.bence@med.semmelweis-univ.hu.

Bálint Szilveszter (B)

MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.

Noémi Daradics (N)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary.

Kálmán Benke (K)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary.

Roland Stengl (R)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary.

Márton Kolossváry (M)

MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.

Miklós Pólos (M)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary.

Tamás Radovits (T)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.

Péter Ferdinandy (P)

Department of Pharmacology and Pharmacotherapy, Semmelweis University, Üllői út 26, Budapest, H-1085, Hungary.

Béla Merkely (B)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.

Pál Maurovich-Horvat (P)

MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.

Zoltán Szabolcs (Z)

Heart and Vascular Center, Semmelweis University, Városmajor u. 68, Budapest, H-1122, Hungary.
Hungarian Marfan Foundation, Városmajor u. 68, Budapest, H-1122, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH